<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367995">
  <stage>Registered</stage>
  <submitdate>9/11/2015</submitdate>
  <approvaldate>19/11/2015</approvaldate>
  <actrnumber>ACTRN12615001263583</actrnumber>
  <trial_identification>
    <studytitle>Can Phytochemicals Alter Intestinal Carbohydrate Digestion in Ileostomates</studytitle>
    <scientifictitle>Phytochemicals and carbohydrate digestion in ileostomates as measured by ileal carbohydrate excretion</scientifictitle>
    <utrn>U1111-1176-3349 </utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will adhere to a low starch and sucrose dietary pattern for 4 days (Monday-Thursday) as set by the research dietitian; with the exception of a daily high starch/high sucrose breakfast test meal. Monday is a planned run in day and Wednesday a washout day. On Tuesday and Thursday participants will be randomised to consume one of two test drinks with the breakfast meal. Drinks are identical with the exception of one containing a phytonutrient rich sugar cane molasses extract, made up in water to a volume of 355mL.  Dietary compliance is assessed by dietary records. Ileal efflux is collected at regular intervals (2 hourly; 07:00-23:00) for the duration of the study to measure carbohydrate excretion.</interventions>
    <comparator>No treatment control test day. Participants will consume a placebo beverage of 355mL water.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>ileal carbohydrate excretion - AOAC official method 996.11; Prosky gravimetric technique</outcome>
      <timepoint>0-24 hrs post test meal/drink</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>none</outcome>
      <timepoint>none</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>minimal terminal ileum removed</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>History of drug or alcohol abuse
Participation in a study within 30 days of commencement of the present study.
Use of any medication or supplement that may, in the opinion of the Principal Investigator, interfere with the study or small intestinal function.
Definite or suspected personal or family history of intolerance or adverse events following consumption of foods which may be tested in this study.
Person considered, in the opinion of the Principle Investigator, to be unwilling, unlikely or unable to comprehend or comply with the study protocol.
Unwilling or unable to collect ileal effluent as required.
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence>simple randomisation by computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>none</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>13/11/2015</actualstartdate>
    <anticipatedenddate>21/12/2015</anticipatedenddate>
    <actualenddate />
    <samplesize>6</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <postcode>5000 - Adelaide</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>CSIRO Food and Nutrition</primarysponsorname>
    <primarysponsoraddress>Gate 13 Kintore Ave
Adelaide SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>The Product Makers (TPM)</fundingname>
      <fundingaddress>50-60 Popes Rd
Keysborough VIC 3173</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress>none</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The objective of the study is to determine whether consumption of sugar cane molasses extract (SCE) reduces dietary carbohydrate absorption from the small intestine</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CSIRO Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 10041
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>27/10/2015</ethicapprovaldate>
      <hrec>10/2015</hrec>
      <ethicsubmitdate>18/08/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Bianca Benassi-Evans</name>
      <address>CSIRO Food and Nutrition
Gate 13 Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 8 83038982</phone>
      <fax />
      <email>bianca.benassi-evans@csiro.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Bianca Benassi-Evans</name>
      <address>CSIRO Food and Nutrition
Gate 13 Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 8 83038982</phone>
      <fax />
      <email>bianca.benassi-evans@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tony Bird</name>
      <address>CSIRO Food and Nutrition
Gate 13 Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 8 83038902</phone>
      <fax />
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Bianca Benassi-Evans</name>
      <address>CSIRO Food and Nutrition
Gate 13 Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 8 83038982</phone>
      <fax />
      <email>bianca.benassi-evans@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>